Dr. Salvador Augustin, researcher at the Vall d'Hebron Barcelona Hospital Campus, has won the Young Investigator Award of the ICS, which was delivered this morning in Girona, during the celebration of the http://www.idibgi.org/jornadesics2016 8th Research Day, dedicated to obesity and diabetes. Dr. Wifredo Ricart, from Doctor Josep Trueta Hospital of Girona. has won the Lifetime Researcher Achievement Award ICS, while Dr. Llorenç Caballeria, from the Primary Care Team (EAP) Premià, has won the Lifetime Achievement in Primary Care Research Award.This is the second year that a researcher at the Vall d'Hebron Hospital Barcelona Hospital Campus wins this award, because Dr. Israel Molina, researcher of the http://www.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186953&t=Enfermedades%20Infecciosas Infectious Diseases research group at Vall d'Hebron Research Institute (VHIR), ex aequo won the Young Investigator Award last year. Dr. Salvador Augustin (39 years old) is an associate physician in the Haepatology Service of Hospital Vall d'Hebron and researcher at the http://es.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=187010&t=Enfermedades%20Hep%E1ticas Group of Liver Diseases at VHIR. He is a specialist in internal medicine and a doctorate in medicine with a thesis on the prognosis of acute bleeding from esophageal varices. His main contribution has been the improvement of predicting risk of bleeding. His current research focuses on hepatic steatosis (fatty liver) linked to nutrition. He has published 17 papers in refereed journals, which have been cited more than 500 times.About 200 researchers from Catalonia have met in Girona on a day that has consisted of three lectures and two symposia, one dedicated to obesity and other to diabetes. Two VHIR researchers have participated. Dr. Ramon Villalonga, member of the Department of Surgery at the University Hospital Vall d'Hebron and VHIR researcher, spoke about the latest advances in bariatric surgery robotics at the first symposium. At the round table were discussions about which patients to whom such operations can be performed, taking into account the body mass index from which it is advisable to carry out the surgery.Dr. Cristina Hernández, of http://es.vhir.org/portal1/grup-equip.asp?s=recerca&contentid=186789&t=Diabetes%20y%20Metabolismo Diabetes and Metabolism group at VHIR, participated in the second symposium, where recent advances in the treatment of diabetes were presented. He has specifically talked about the link between neurodegeneration and diabetic retinopathy. During the round table it was explained that a diabetic person has a higher risk of developing Alzheimer's disease and that the study of retinal neurodegeneration can help diagnose dementia earlier.